comparemela.com

Latest Breaking News On - Prathyusha duraibabu - Page 1 : comparemela.com

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript

Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.

Brisbane
Queensland
Australia
Point-richmond
California
United-states
Lisa-rojkjaer
Nathalie-dubois-stringfellow
Areena-patel
Prathyusha-duraibabu
Kamy-pooler
Andreas-argyrides

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Sangamo First Quarter 2023 Teleconference Call. At this time, all participants are in a listen-only mode.

Texas
United-states
California
France
Valbonne
Provence-alpes-côd-azur
Brisbane
Queensland
Australia
American
America
Mark-mcclung

Sangamo Therapeutics, Inc. (SGMO) CEO Sandy Macrae on Q2 2022 Results - Earnings Call Transcript

Sangamo Therapeutics, Inc. (NASDAQ:NASDAQ:SGMO) Q2 2022 Earnings Conference Call August 04, 2022 04:30 PM ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief.

Australia
Italy
United-states
Canada
Washington
America
American
Gregory-harrison
Jason-shieh
Bettina-cockroft
Gena-wang
Harshita-polishetty

Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Call Transcript

ORGO earnings call for the period ending December 31, 2021.

China
California
United-states
La-jolla
Massachusetts
Canton
Steven-lichtman-oppenheimer
Dave-francisco
Prathyusha-duraibabu
Steven-lichtman
Gary-gillheeney
Ryan-zimmerman

Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Call Transcript

ORGO earnings call for the period ending December 31, 2021.

China
California
United-states
La-jolla
Massachusetts
Canton
Prathyusha-duraibabu
Dave-francisco
Gary-gillheeney
Michael-driscoll
Exchange-commission
Organogenesis-holdings-inc

vimarsana © 2020. All Rights Reserved.